Well said seel. We really have to remember that efficacy is a secondary goal here, as important as it is to us investors. We are extremely fortunate that dana farber set up the trial with so many opportunities to demonstrate efficacy, but we still have to play by the rules and start off at a low dose to determine safety. We will get our blockbuster info soon enough, patience!